Philippe Conus, MD

Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland

JCP
Associations of Valproate Doses With Weight Gain in Psychiatric Patients
Original Research

March 27, 2024

Valproate dose increase of 500 mg was associated with a weight change of +0.52% per month over a year. No associations were found between valproate dose and blood glucose,...
Claire Grosu, William Hatoum, Marianna Piras, et al
JCP
Daily Dose Effects of Risperidone on Metabolic Parameters
Original Research

May 9, 2022

This study investigated whether dose is a factor in the development of metabolic side effects with atypical antipsychotics.
Marianna Piras, Céline Dubath, Mehdi Gholam, et al
JCP
Original Research

March 31, 2020

Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in...
Céline Dubath, Aurélie Delacrétaz, Anaׯs Glatard, et al
JCP
Original Research

April 9, 2019

How bad is too bad? Lipid worsening of 5% or more in the early stages of treatment with SGAs predicts a negative metabolic outcome in adults. Is it the...
Aurélie Delacrétaz, Frederik Vandenberghe, Anaׯs Glatard, et al
JCP
Original Research

May 25, 2016

What's the impact of childhood trauma on a patient's psychopathological profile? To answer this question, Dr Alameda and colleagues looked at whether early psychosis patients with trauma before age...
Luis Alameda, Philippe Golay, Philipp S. Baumann, et al
JCP
Original Research

November 25, 2015

Frederik Vandenberghe, Mehdi Gholam-Rezaee, Núria Saig×­-Morgui, et al
JCP
Original Research

September 21, 2010

Michael Berk, Ahmed Munib, Olivia Dean, et al
JCP
Original Research

October 14, 2005

Benno G. Schimmelmann, Philippe Conus, Jane Edwards, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe